Galenicum Health to launch in Southeast Asia

March 9, 2018

Galenicum Health is preparing to launch in the Southeast Asian market for the first time in history, starting with a product in Singapore—the first of what will be a larger product portfolio in the future.

Following Singapore, the company plans to launch the vitae line in other markets such as Vietnam, Taiwan, Hong Kong and Thailand in the coming months.

It is important to note that all of the products in the vitae line are bioequivalent following the EMA guidelines, and offer high-quality affordable treatment to all patients.